AGM Details

  • Meeting Date: Friday, September 11, 2026
  • Time: 04:00 PM (IST)
  • Mode: Video Conferencing (VC) / Other Audio Visual Means (OAVM) without physical presence
  • Record Date: Friday, September 04, 2026 for determining voting eligibility
  • Remote E-voting Period: September 08, 2026 (9:00 AM) to September 10, 2026 (5:00 PM)

Ordinary Business Items

1. Adoption of Financial Statements

To receive, consider and adopt the Audited Standalone and Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with Reports of the Board of Directors and Statutory Auditor.

2. Declaration of Dividend

  • Confirmation of interim dividend at rate of ₹0.80 per equity share (face value ₹2) declared by Board on September 27, 2025 for FY 2025-26
  • Declaration of final dividend at rate of ₹0.05 per equity share (face value ₹1) out of profits of FY 2025-26
  • Dividend payable to shareholders on register as of September 04, 2026
  • Payment to be made on or before September 30, 2026

3. Re-appointment of Director

  • Re-appointment of Mrs. Aarti Mitesh Jhunjhunwala (DIN: 07759722) as director who retires by rotation
  • She has offered herself for re-appointment

Special Business Items

4. Ratification of Cost Auditor Remuneration

  • Appointment of M/s. V. J. Talati & Co., Cost Accountants (Firm Registration No. R/00213) as Cost Auditor for FY 2026-27
  • Remuneration: ₹50,000 per annum plus applicable taxes and reimbursement of actual travel and out-of-pocket expenses
  • Increased from previous year's remuneration of ₹45,000 due to enhanced scope of cost audit
  • Board approved appointment on May 15, 2026 based on Audit Committee recommendation

5. Fundraising Proposal

  • Amount: Up to ₹800 crore (Rupees Eight Hundred Crores)
  • Instruments: Equity shares and/or other securities convertible into equity shares or non-convertible debt instruments along with warrants
  • Methods: Private placement, follow-on public offering (FPO), preferential issue, qualified institutions placement (QIP), or combination
  • Purpose: Capital expenditure, working capital requirements, general corporate purposes, business expansion and diversification through inorganic growth opportunities
  • Key Terms:
  • Securities to be fully paid up and in dematerialized form
  • Equity shares to rank pari passu with existing shares
  • Minimum 10% allocation to mutual funds
  • QIP allotment to be completed within 365 days from shareholder approval
  • Maximum 5% discount permitted on QIP floor price
  • Securities not eligible for sale for one year from allotment date
  • No single allottee to receive more than 50% of issue size
  • Authorization: Board authorized to take all necessary actions, appoint intermediaries, and determine final terms and conditions

6. Material Related Party Transactions

  • Parties: Fineotex Biotex Healthguard FZE (wholly owned foreign subsidiary) and Crudechem Technology LLC (foreign step-down subsidiary)
  • Transaction Value: Aggregate up to ₹500 crore for FY 2026-27
  • Nature: Sale, purchase and/or supply of goods or services (₹100 crore) and giving loan & advances for business purpose (₹400 crore)
  • Rationale: To facilitate seamless business operations, optimize resource utilization, improve operational efficiencies, and strengthen supply chain integration following acquisition of CCT Group
  • Pricing: Arm's length basis using Transactional Net Margin Method (TNMM)
  • Previous Transactions:
  • FY 2025-26: Loan given ₹13.14 crore, Technical fees received ₹2.03 crore
  • Current FY (up to preceding quarter): Loan given ₹62.99 crore, Technical fees ₹0.93 crore, Interest ₹0.92 crore
  • Financial Impact:
  • Represents 62.09% of company's annual consolidated turnover for immediately preceding financial year
  • Represents 29,382.53% of subsidiary's annual standalone turnover
  • Represents 198.43% of related party's annual consolidated turnover
  • CCT Financials (FY 2025-26): Turnover ₹251.97 crore, Profit After Tax ₹35.94 crore, Net Worth ₹38.12 crore

Director Details for Re-appointment

  • Name: Mrs. Aarti Jhunjhunwala
  • DIN: 07759722
  • Age: 42 years (Date of Birth: 24/01/1983)
  • First Appointment: 14/08/2018
  • Qualifications: Masters in Accounts and Taxation
  • Experience: More than 16 years in international business and global markets
  • Remuneration (FY 2025-26): ₹1,07,40,000
  • Shareholding: 8,50,500 equity shares
  • Board Meeting Attendance: 7 out of 7 meetings in 2025-2026
  • Committee Positions: Chairperson of Women Welfare Committee, Member of Administrative Committee

Voting and Participation Arrangements

  • Remote e-voting through NSDL platform
  • VC/OAVM facility available for 1000 members on first-come-first-served basis (exceptions for large shareholders, promoters, institutional investors, directors, KMPs)
  • Scrutinizer: Mr. Hemant Shetye appointed to oversee voting process
  • Results to be uploaded on company website and stock exchanges after meeting

Dividend Payment Details

  • Payment to be made through electronic means via NACH for physical shareholders
  • Demat shareholders' bank particulars registered with depositories will be used
  • TDS applicable as per Finance Act, 2020
  • Shareholders can submit Form 15G/15H for non-deduction by September 04, 2026